Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Not Determined”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Testing effectiveness (Phase 2)Study completedNCT00366379
What this trial is testing

A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 127
Not applicableUnknownNCT05860738
What this trial is testing

The Effect of Autoclave Cycles on the Mechanical Properties and Surface Roughness of NITI Archwires

Who this might be right for
Not Determined
Cairo University 20
Testing effectiveness (Phase 2)Study completedNCT00853047
What this trial is testing

Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy

Who this might be right for
Carcinoid Syndrome
Lexicon Pharmaceuticals 23
Testing effectiveness (Phase 2)Study completedNCT00045422
What this trial is testing

Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT00346099
What this trial is testing

Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum

Who this might be right for
Rectal CancerNeoplasm Metastasis
NSABP Foundation Inc
Testing effectiveness (Phase 2)Ended earlyNCT05005182
What this trial is testing

Luspatercept With or Without Hydroxyurea for the Treatment of Myelodysplastic/Myeloproliferative Neoplasms With Ring Sideroblasts and Thrombocytosis or Unclassifiable With Ring Sideroblasts

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis, Not Otherwise SpecifiedMyelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified
Mayo Clinic 3
Testing effectiveness (Phase 2)Study completedNCT02624492
What this trial is testing

To Determine the Dose of BI 836826-GemOx and the Efficacy of BI 836826-GemOx Versus R-GemOx in Patients With Relapsed/Refractory DLBCL

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Boehringer Ingelheim 21
Testing effectiveness (Phase 2)Study completedNCT01359644
What this trial is testing

Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) in Patients Who Have Previously Not Received the Standard of Care

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 350
Not applicableStudy completedNCT03131401
What this trial is testing

Prevalence of LF Infection in Districts Not Included in LF Control Activities

Who this might be right for
Lymphatic FilariasesOnchocerciasis
Noguchi Memorial Institute for Medical Research 3,736
Large-scale testing (Phase 3)Active Not RecruitingNCT05917509
What this trial is testing

Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy

Who this might be right for
HIV Infections
ViiV Healthcare 171
Testing effectiveness (Phase 2)Study completedNCT01455090
What this trial is testing

Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 320
Testing effectiveness (Phase 2)Study completedNCT03484702
What this trial is testing

Trial to Determine the Efficacy and Safety of JCAR017 in Adult Participants With Aggressive B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Celgene 113
Testing effectiveness (Phase 2)Study completedNCT00006053
What this trial is testing

STI571 in Treating Patients With Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa

Who this might be right for
Leukemia
Novartis
Early research (Phase 1)Looking for participantsNCT05549661
What this trial is testing

Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms

Who this might be right for
Recurrent Chronic Myelomonocytic LeukemiaRefractory Chronic Myelomonocytic LeukemiaMyelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified+3 more
Mayo Clinic 25
Large-scale testing (Phase 3)Study completedNCT00689936
What this trial is testing

Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 1,623
Early research (Phase 1)Study completedNCT00482521
What this trial is testing

CC-4047 in Treating Patients With Advanced Solid Tumors That Did Not Respond to Treatment

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT03775486
What this trial is testing

Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)

Who this might be right for
Non-small Cell Lung Cancer NSCLC
AstraZeneca 401
Testing effectiveness (Phase 2)Study completedNCT02624167
What this trial is testing

Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia

Who this might be right for
Chronic Schizophrenia
Newron Pharmaceuticals SPA 90
Not applicableStudy completedNCT00002310
What this trial is testing

SP-303T Applied to the Skin of Patients With Herpes Simplex Virus (HSV) Infection and AIDS Who Have Not Had Success With Acyclovir

Who this might be right for
Herpes SimplexHIV Infections
Shaman Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00270075
What this trial is testing

Determine the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Not Anemic and Who Will be Undergoing Orthopedic or Heart and Blood Vessel Surgery

Who this might be right for
Blood TransfusionBlood Transfusion, AutologousOrthopedic Procedures+2 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 80
Load More Results